BASIS FOR AGREEMENT. Corixa has samples of normal and diseased tissues and wants to obtain information about the difference between those tissues. Corixa has or will make certain nucleic acid material including cDNA for constructing microarrays ("PCR Product" described in Section 2 below) and ribonucleic acid samples from the normal and diseased tissues for hybridizing to microarrays ("Sample RNA"). Corixa desires to know which genes are expressed in cells in the diseased tissue relative to the normal tissue. Rosetta has expertise in the area of using microarrays and analyzing microarray data to determine gene expression. The purpose of this Agreement is to set forth the terms and conditions under which (a) Corixa will supply Rosetta with PCR Product and Sample RNA, and (b) Rosetta will conduct experiments using microarrays constructed using PCR Product and hybridized with Sample RNA and provide Corixa with an analysis of the data generated from such experiments. The procedures that each party will follow in performing this Agreement are set forth in the provisions herein and in Appendix A hereto, which is incorporated herein by this reference.
BASIS FOR AGREEMENT. Monsanto desires to conduct a pilot project that will evaluate two aspects of Rosetta's technologies. One part of the project will evaluate the Resolver-TM- Expression Data Analysis System ("Resolver-TM- System"). Rosetta and Monsanto both have possession of gene expression data that will be used for evaluation of the Resolver. The second part of the project will evaluate Rosetta's FlexJet-TM- microarray technology including arrays ("F1exJet~ Arrays") and array design capabilities ("Array Design"). For evaluation of the FlexJet~ Arrays and Array Design, Monsanto has possession of gene sequence information that will be provided to Rosetta for the construction of arrays and Monsanto has possession of nucleic acid material that will be provided to Rosetta for hybridizing to microarrays ("Sample RNA"). Rosetta has expertise in the area of using microarrays and analyzing microarray data to determine gene expression. The purpose of this Agreement is to set forth the terms and conditions under which (a) Monsanto will evaluate the Resolver, (b) Rosetta will conduct experiments using FlexJet-TM- Arrays constructed using sequence information provided by Monsanto and hybridized with Sample RNA and provide Monsanto with an analysis of the data generated from such experiments, (c) both parties will evaluate the data generated, and (d) the conditions under which a follow-on collaboration between Monsanto and Rosetta would take place.
BASIS FOR AGREEMENT. A Change Order shall be based upon agreement among City and Design-Builder. A Construction Change Directive may or may not be agreed to by Design-Builder.
BASIS FOR AGREEMENT. The Franchisor has developed methods for establishing, operating and promoting businesses engaged in the business of TAX COMPANY/FINANCIAL INSTITUTE using the service xxxx and related trade names and trademarks (the "Marks") and the Franchisor's proprietary methods of doing business (the "Licensed Methods"). The Franchisor grants the right to others to develop and operate a MZBIZ TAX SERVICES LLC franchise, under the Marks and pursuant to the Licensed Methods. The Franchisee desires to establish a MZBIZ TAX SERVICES LLC franchise at a location identified herein or to be later identified, and the Franchisor desires to grant the Franchisee the right to operate a MZBIZ TAX SERVICES LLC franchise at such location under the terms and conditions which are contained in this Agreement.
BASIS FOR AGREEMENT. The following chronology and purposes form the basis for the agreements hereunder:
BASIS FOR AGREEMENT. The PARTIES acknowledge that they have entered into this Agreement of their own free will, and have not relied on any inducement by the other party to enter into this Agreement (even if such inducement occurred), nor have they relied on any warranty or representation by the other party not explicity set forth in this Agreement (even if such warranties or representations were made). 5.16
BASIS FOR AGREEMENT. The Company is engaged in the business of developing inventions, know-how and trade secrets, and marketing and selling products pertaining to the Technological Field (as hereinafter defined) ("Business"). Consultant is an experienced executive in the pharmaceutical field and desires to aid in the Company's executive management and leadership. The purpose of this Agreement is to set forth the terms and conditions under which Consultant will provide consulting services and work product.
BASIS FOR AGREEMENT. 2.1 Pursuant to the provisions of the Workforce Innovation and Opportunity Act (WIOA) and its implementing regulations, this agreement is written for the purpose of providing incumbent worker training.
BASIS FOR AGREEMENT. This agreement supplements the existing terms of employment between Aspen and the Employee, including the Change in Control Agreement dated August 12, 1997 ("Change in Control Agreement"), which remains in full force and effect. Aspen is continuing to employ the Employee as a key employee of Aspen and has determined that Employee's services are essential to the successful operation and future of Aspen. Employee currently holds the positions of Chief Legal Officer and General Counsel, and Chief Strategy Officer. Aspen has determined that it is in its best interests to secure certain financial and employment commitments from Employee in consideration of providing certain severance and compensation commitments to Employee.
BASIS FOR AGREEMENT. A. The Ports of Tacoma and Seattle (“Ports”) are separate port districts governed by locally elected port commissioners. They are 30 miles apart on Puget Sound. There are over 75 different ports in Washington. Washington state law provides for local control of port facilities, and also allows each port to exercise any of its powers jointly with any other port by mutual agreement.
